CVS Health (NYSE:CVS), Humana (NYSE:HUM), Molina Healthcare (NYSE:MOH), and UnitedHealth Group (NYSE:UNH) saw an upswing ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between ...

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...

Elevance Health led the insurance sector higher after it beat Wall Street’s sales and profit targets and raised its dividend.

Newsweek sought email comment on Monday from UnitedHealth and two other companies named in the lawsuit—CVS Health's CVS Caremark and Cigna's Express ... of UnitedHealth Group's insurance wing ...

They accuse the company of forming agreements with insurers—UnitedHealth Group, Elevance Health, Aetna and Cigna are listed as "co-conspirators"—to set out-of-network prices using a common ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...